Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023;48(1):202-208.
doi: 10.1159/000530168. Epub 2023 Mar 20.

Prevalence of Cognitive Impairment in Peritoneal Dialysis Patients and Associated Factors

Aleksandra Golenia  1 , Norbert Zolek  2 , Piotr Olejnik  3 , Ewa Wojtaszek  4 , Tomasz Glogowski  4 , Jolanta Malyszko  4
Affiliations

Prevalence of Cognitive Impairment in Peritoneal Dialysis Patients and Associated Factors

Aleksandra Golenia et al. Kidney Blood Press Res. 2023.

Abstract

Background: Cognitive impairment (CI) in patients with chronic kidney disease, including those treated with renal replacement therapy, is a growing problem worldwide.

Objectives: The study aimed to assess the prevalence of CI and associated factors in patients undergoing peritoneal dialysis (PD).

Methods: In this cross-sectional study, 18 consecutive patients with PD therapy and 15 controls were evaluated for CI using the Addenbrooke's Cognitive Examination III (ACE III) test.

Results: The prevalence of CI was 33% in patients and 27% in the control group and was not statistically significant. A higher prevalence of CI was found in subjects aged ≥65 years old than in those <65 years old (p = 0.02), but only in the control group. The prevalence of CI in PD patients over and under 65 years of age did not differ statistically significantly (p = 0.12). Memory and verbal fluency were the most affected cognitive domain in PD patients with CI (p = 0.00, p = 0.04, respectively). There was a significant correlation between higher educated PD patients and the ACE III test results. The duration of dialysis did not affect the results of the cognitive screening test.

Conclusions: CI is a growing problem in the course of chronic kidney disease and dialysis therapy. It seems that cognitive problems may occur in patients undergoing PD at a younger age than in the general population with particularly affected memory and verbal fluency. Higher educated patients score better on the cognitive screening test.

Keywords: Addenbrooke’s Cognitive Examination III test; Chronic kidney disease; Cognitive impairment; Peritoneal dialysis; Screening test.

PubMed Disclaimer

Conflict of interest statement

Authors report no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Correlation coefficient between PD patients and years of education and the results of the ACE III test (left panel) and correlation coefficient for control between years of education and the results of the ACE III test (right panel).
Fig. 2.
Fig. 2.
ROC curve for classifier of PD patients representing the norm based on years of education.
See this image and copyright information in PMC

References

    1. Madero M, Gul A, Sarnak MJ. Cognitive function in chronic kidney disease. Semin Dial. 2008;21(1):29–37. 10.1111/j.1525-139X.2007.00384.x. - DOI - PubMed
    1. Cullen B, O’Neill B, Evans JJ, Coen RF, Lawlor BA. A review of screening tests for cognitive impairment. J Neurol Neurosurg Psychiatry. 2007;78(8):790–9. 10.1136/jnnp.2006.095414. - DOI - PMC - PubMed
    1. Luchsinger JA. Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis. 2012;3 Suppl 2(0):S185–98. 10.3233/JAD-2012-111433. - DOI - PMC - PubMed
    1. Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement. 2015;11(6):718–26. 10.1016/j.jalz.2015.05.016. - DOI - PubMed
    1. Kurella M, Luan J, Yaffe K, Chertow GM. Validation of the kidney disease quality of life (KDQOL) cognitive function subscale. Kidney Int. 2004;66(6):2361–7. 10.1111/j.1523-1755.2004.66024.x. - DOI - PubMed